Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NIT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | GAGE12G | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | HHEX | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | NTNG2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | REEP5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | CTSK | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | TNFRSF18 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | MS4A4E | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | MRPL34 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | FCRL4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |